Moreau; Monique

Patent Applications and Registrations

Patent applications and USPTO patent grants for Moreau; Monique.The latest application filed is for "meningococcal vaccine based on lipooligosaccharide (los) originating from modified neisseria meningitidis strains of immunotype l6".

Company Profile

2.12.13

Moreau; Monique - Lyon FR
Moreau; Monique - Lyons N/A FR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Meningococcal vaccine based on lipooligosaccharide (LOS) originating from modified Neisseria meningitidis strains of immunotype L6 App 20190117684 - Mistretta; Noelle ; et al.	2019-04-25
Meningococcal vaccine based on lipooligosaccharide (LOS) originating from modified Neisseria meningitidis strains of immunotype L6 Grant 10,137,145 - Mistretta , et al. November 27, 2	2018-11-27
Meningococcal vaccine based on lipooligosaccharide (LOS) originating from modified Neisseria meningitidis strains of immunotype L6 App 20180036339 - Mistretta; Noelle ; et al.	2018-02-08
Detoxification method for lipopolysaccharide (LPS) or lipid A of Gram-negative bacteria App 20170326221 - Haensler; Jean ; et al.	2017-11-16
Meningococcal vaccine based on lipooligosaccharide (LOS) originating from modified Neisseria meningitidis strains of immunotype L6 Grant 9,669,052 - Mistretta , et al. June 6, 2	2017-06-06
Meningococcal vaccine based on lipooligosaccharide (LOS) originating from modified Neisseria meningitidis strains of immunotype L6 App 20160045535 - Mistretta; Noelle ; et al.	2016-02-18
Meningococcal vaccine based on lipooligosaccharide (LOS) originating from modified Neisseria meningitidis strains of immunotype L6 Grant 9,132,181 - Mistretta , et al. September 15, 2	2015-09-15
Meningococcal Vaccine Based on Lipooligosaccharide (LOS) and Neisseria Meningitidis Protein App 20120156281 - Haensler; Jean ; et al.	2012-06-21
Meningococcal vaccine based on lipooligosaccharide (LOS) originating from modified Neisseria meningitidis strains of immunotype L6 App 20100330160 - Mistretta; Noelle ; et al.	2010-12-30
Detoxification method for lipopolysaccharide (LPS) or lipid A of gram-negative bacteria App 20100291192 - Haensler; Jean ; et al.	2010-11-18
Conjugates obtained by reductive amination of the pneumococcus serotype 5 capsular polysaccharide Grant 7,812,006 - Mistretta , et al. October 12, 2	2010-10-12
Polymyxin B Analogs for LPS Detoxification App 20090203881 - Porro; Massimo ; et al.	2009-08-13
Polymyxin B analogs for LPS detoxification Grant 7,507,718 - Porro , et al. March 24, 2	2009-03-24
IgA1 protease fragment as carrier peptides Grant 7,235,242 - Achtman , et al. June 26, 2	2007-06-26
Polymyxin B analogs for LPS detoxification App 20060281684 - Porro; Massimo ; et al.	2006-12-14
IgA1 protease fragment as carrier peptides App 20040203108 - Achtman, Mark ; et al.	2004-10-14
Conjugates obtained by reductive amination of the pneumococcus serotype 5 capsular polysaccharide App 20040170638 - Mistretta, Noelle ; et al.	2004-09-02
Method for the reductive amination of polysaccharides Grant 6,596,861 - Moreau July 22, 2	2003-07-22
Polysaccharide-peptide-conjugates Grant 6,472,506 - Moreau , et al. October 29, 2	2002-10-29
Oligosaccharide derived from an antigenic polysaccharide obtained from a pathogenic agent Grant 6,045,805 - Moreau April 4, 2	2000-04-04
Oligosaccharide derived from an antigenic polysaccharide obtained from a pathogenic agent Grant 6,007,818 - Moreau December 28, 1	1999-12-28

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.